Publisher: Medknow Publishers   (Total: 426 journals)

 A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z  

        1 2 3 | Last   [Sort by number of followers]   [Restore default list]

Showing 1 - 200 of 426 Journals sorted alphabetically
Acta Medica Intl.     Open Access   (SJR: 0.101, CiteScore: 0)
Advanced Arab Academy of Audio-Vestibulogy J.     Open Access  
Advanced Biomedical Research     Open Access  
Advances in Human Biology     Open Access   (Followers: 5)
Advances in Skeletal Muscle Function Assessment     Open Access  
African J. for Infertility and Assisted Conception     Open Access   (Followers: 1)
African J. of Medical and Health Sciences     Open Access   (Followers: 3)
African J. of Paediatric Surgery     Open Access   (Followers: 7, SJR: 0.25, CiteScore: 1)
African J. of Trauma     Open Access   (Followers: 1)
Ain-Shams J. of Anaesthesiology     Open Access   (Followers: 2)
Al-Azhar Assiut Medical J.     Open Access   (Followers: 2)
Al-Basar Intl. J. of Ophthalmology     Open Access   (Followers: 1)
Alexandria J. of Pediatrics     Open Access   (Followers: 1)
Ancient Science of Life     Open Access   (Followers: 5)
Anesthesia : Essays and Researches     Open Access   (Followers: 10)
Annals of African Medicine     Open Access   (Followers: 2, SJR: 0.258, CiteScore: 1)
Annals of Bioanthropology     Open Access   (Followers: 5)
Annals of Cardiac Anaesthesia     Open Access   (Followers: 14, SJR: 0.308, CiteScore: 1)
Annals of Indian Academy of Neurology     Open Access   (Followers: 3, SJR: 0.434, CiteScore: 1)
Annals of Indian Academy of Otorhinolaryngology Head and Neck Surgery     Open Access  
Annals of Indian Psychiatry     Open Access  
Annals of Maxillofacial Surgery     Open Access   (Followers: 6)
Annals of Medical and Health Sciences Research     Open Access   (Followers: 7)
Annals of Nigerian Medicine     Open Access   (Followers: 1)
Annals of Pediatric Cardiology     Open Access   (Followers: 12, SJR: 0.352, CiteScore: 1)
Annals of Saudi Medicine     Open Access   (SJR: 0.238, CiteScore: 1)
Annals of Thoracic Medicine     Open Access   (Followers: 6, SJR: 0.524, CiteScore: 1)
Annals of Tropical Medicine and Public Health     Open Access   (Followers: 14, SJR: 0.152, CiteScore: 0)
Annals of Tropical Pathology     Open Access  
Apollo Medicine     Open Access  
APOS Trends in Orthodontics     Open Access   (Followers: 1)
Arab J. of Interventional Radiology     Open Access   (Followers: 1)
Archives of Cardiovascular Imaging     Open Access   (Followers: 2, SJR: 0.187, CiteScore: 0)
Archives of Intl. Surgery     Open Access   (Followers: 11, SJR: 0.302, CiteScore: 1)
Archives of Medicine and Health Sciences     Open Access   (Followers: 4)
Archives of Medicine and Surgery     Open Access  
Archives of Pharmacy Practice     Open Access   (Followers: 11, SJR: 0.102, CiteScore: 0)
Archives of Trauma Research     Open Access   (Followers: 4, SJR: 0.37, CiteScore: 2)
Asia Pacific J. of Clinical Trials : Nervous System Diseases     Open Access  
Asia-Pacific J. of Oncology Nursing     Open Access   (Followers: 5)
Asian J. of Andrology     Open Access   (Followers: 1, SJR: 0.856, CiteScore: 2)
Asian J. of Neurosurgery     Open Access   (Followers: 2)
Asian J. of Oncology     Open Access   (Followers: 2)
Asian J. of Transfusion Science     Open Access   (Followers: 1, SJR: 0.35, CiteScore: 1)
Asian Pacific J. of Reproduction     Open Access   (SJR: 0.227, CiteScore: 1)
Asian Pacific J. of Tropical Biomedicine     Open Access   (Followers: 2, SJR: 0.491, CiteScore: 2)
Asian Pacific J. of Tropical Medicine     Open Access   (Followers: 1, SJR: 0.561, CiteScore: 2)
Astrocyte     Open Access  
Avicenna J. of Medicine     Open Access   (Followers: 1)
AYU : An international quarterly journal of research in Ayurveda     Open Access   (Followers: 6)
Benha Medical J.     Open Access  
Biomedical and Biotechnology Research J.     Open Access   (Followers: 1)
BLDE University J. of Health Sciences     Open Access  
Brain Circulation     Open Access   (Followers: 1)
Bulletin of Faculty of Physical Therapy     Open Access   (Followers: 2)
Canadian J. of Rural Medicine     Full-text available via subscription   (Followers: 1, SJR: 0.202, CiteScore: 0)
Cancer Translational Medicine     Open Access   (Followers: 2)
Cardiology Plus     Open Access   (Followers: 1)
Chinese Medical J.     Open Access   (Followers: 10, SJR: 0.52, CiteScore: 1)
CHRISMED J. of Health and Research     Open Access   (Followers: 2)
Clinical Cancer Investigation J.     Open Access  
Clinical Dermatology Review     Open Access   (Followers: 5)
Clinical Trials in Degenerative Diseases     Open Access  
Clinical Trials in Orthopedic Disorders     Open Access   (Followers: 2)
Community Acquired Infection     Open Access  
Conservation and Society     Open Access   (Followers: 9, SJR: 0.811, CiteScore: 2)
Contemporary Clinical Dentistry     Open Access   (Followers: 5, SJR: 0.353, CiteScore: 1)
Current Medical Issues     Open Access   (Followers: 2)
CytoJ.     Open Access   (Followers: 2, SJR: 0.543, CiteScore: 1)
Delta J. of Ophthalmology     Open Access  
Dental Hypotheses     Open Access   (Followers: 5, SJR: 0.152, CiteScore: 0)
Dental Research J.     Open Access   (Followers: 14, SJR: 0.416, CiteScore: 1)
Dentistry and Medical Research     Open Access   (Followers: 1)
Digital Medicine     Open Access  
Drug Development and Therapeutics     Open Access  
Education for Health     Open Access   (Followers: 8, SJR: 0.242, CiteScore: 0)
Education in the Health Professions     Open Access   (Followers: 1)
Egyptian J. of Bronchology     Open Access  
Egyptian J. of Cardiothoracic Anesthesia     Open Access  
Egyptian J. of Cataract and Refractive Surgery     Open Access   (Followers: 1, SJR: 1.799, CiteScore: 2)
Egyptian J. of Chest Diseases and Tuberculosis     Open Access   (Followers: 3, SJR: 0.155, CiteScore: 0)
Egyptian J. of Dermatology and Venerology     Open Access   (Followers: 1)
Egyptian J. of Haematology     Open Access   (Followers: 1)
Egyptian J. of Internal Medicine     Open Access   (Followers: 1)
Egyptian J. of Obesity, Diabetes and Endocrinology     Open Access   (Followers: 1)
Egyptian J. of Otolaryngology     Open Access   (Followers: 2)
Egyptian J. of Psychiatry     Open Access   (Followers: 1)
Egyptian J. of Surgery     Open Access   (Followers: 1)
Egyptian Nursing J.     Open Access  
Egyptian Orthopaedic J.     Open Access   (Followers: 2)
Egyptian Pharmaceutical J.     Open Access   (Followers: 3)
Egyptian Retina J.     Open Access  
Egyptian Rheumatology and Rehabilitation     Open Access   (Followers: 2)
Endodontology     Open Access  
Endoscopic Ultrasound     Open Access   (SJR: 0.822, CiteScore: 2)
Environmental Disease     Open Access   (Followers: 4)
Eurasian J. of Pulmonology     Open Access  
European J. of Dentistry     Open Access   (Followers: 4, SJR: 0.749, CiteScore: 2)
European J. of General Dentistry     Open Access   (Followers: 2, SJR: 0.12, CiteScore: 0)
European J. of Prosthodontics     Open Access   (Followers: 4)
European J. of Psychology and Educational Studies     Open Access   (Followers: 10, SJR: 0.113, CiteScore: 0)
Fertility Science and Research     Open Access  
Formosan J. of Surgery     Open Access   (SJR: 0.112, CiteScore: 0)
Genome Integrity     Open Access   (Followers: 2, SJR: 0.153, CiteScore: 0)
Glioma     Open Access  
Global J. of Transfusion Medicine     Open Access   (Followers: 1)
Gynecology and Minimally Invasive Therapy     Open Access   (SJR: 0.311, CiteScore: 1)
Hamdan Medical J.     Open Access  
Heart and Mind     Open Access  
Heart India     Open Access   (Followers: 2)
Heart Views     Open Access   (Followers: 2)
Hepatitis B Annual     Open Access   (Followers: 3)
Ibnosina J. of Medicine and Biomedical Sciences     Open Access   (Followers: 1)
IJS Short Reports     Open Access  
Imam J. of Applied Sciences     Open Access  
Indian Dermatology Online J.     Open Access   (Followers: 3)
Indian J. of Allergy, Asthma and Immunology     Open Access   (Followers: 1)
Indian J. of Anaesthesia     Open Access   (Followers: 7, SJR: 0.478, CiteScore: 1)
Indian J. of Burns     Open Access   (Followers: 3)
Indian J. of Cancer     Open Access   (Followers: 1, SJR: 0.361, CiteScore: 1)
Indian J. of Cerebral Palsy     Open Access   (Followers: 1)
Indian J. of Community Medicine     Open Access   (Followers: 2, SJR: 0.37, CiteScore: 1)
Indian J. of Dental Research     Open Access   (Followers: 5, SJR: 0.266, CiteScore: 1)
Indian J. of Dental Sciences     Open Access  
Indian J. of Dentistry     Open Access   (Followers: 1)
Indian J. of Dermatology     Open Access   (Followers: 2, SJR: 0.468, CiteScore: 1)
Indian J. of Dermatology, Venereology and Leprology     Open Access   (Followers: 4, SJR: 0.445, CiteScore: 1)
Indian J. of Dermatopathology and Diagnostic Dermatology     Open Access  
Indian J. of Drugs in Dermatology     Open Access   (Followers: 1, SJR: 0.791, CiteScore: 1)
Indian J. of Endocrinology and Metabolism     Open Access   (Followers: 4, SJR: 0.568, CiteScore: 1)
Indian J. of Health Sciences and Biomedical Research KLEU     Open Access   (Followers: 3)
Indian J. of Medical and Paediatric Oncology     Open Access   (SJR: 0.425, CiteScore: 1)
Indian J. of Medical Microbiology     Open Access   (Followers: 2, SJR: 0.503, CiteScore: 1)
Indian J. of Medical Research     Open Access   (Followers: 4, SJR: 0.656, CiteScore: 1)
Indian J. of Medical Sciences     Open Access   (Followers: 3, SJR: 0.102, CiteScore: 0)
Indian J. of Multidisciplinary Dentistry     Open Access   (Followers: 1)
Indian J. of Nephrology     Open Access   (Followers: 2, SJR: 0.347, CiteScore: 1)
Indian J. of Nuclear Medicine     Open Access   (Followers: 2, SJR: 0.23, CiteScore: 0)
Indian J. of Occupational and Environmental Medicine     Open Access   (Followers: 3, SJR: 0.225, CiteScore: 1)
Indian J. of Ophthalmology     Open Access   (Followers: 4, SJR: 0.498, CiteScore: 1)
Indian J. of Oral Health and Research     Open Access  
Indian J. of Oral Sciences     Open Access   (Followers: 1)
Indian J. of Orthopaedics     Open Access   (Followers: 8, SJR: 0.392, CiteScore: 1)
Indian J. of Otology     Open Access   (Followers: 1, SJR: 0.199, CiteScore: 0)
Indian J. of Paediatric Dermatology     Open Access   (Followers: 2)
Indian J. of Pain     Open Access   (Followers: 2)
Indian J. of Palliative Care     Open Access   (Followers: 7, SJR: 0.454, CiteScore: 1)
Indian J. of Pathology and Microbiology     Open Access   (Followers: 3, SJR: 0.276, CiteScore: 1)
Indian J. of Pharmacology     Open Access   (SJR: 0.412, CiteScore: 1)
Indian J. of Psychiatry     Open Access   (Followers: 2, SJR: 0.408, CiteScore: 1)
Indian J. of Psychological Medicine     Open Access   (SJR: 0.368, CiteScore: 1)
Indian J. of Public Health     Open Access   (Followers: 1)
Indian J. of Radiology and Imaging     Open Access   (Followers: 4)
Indian J. of Research in Homoeopathy     Open Access   (Followers: 2)
Indian J. of Respiratory Care     Open Access   (Followers: 3)
Indian J. of Rheumatology     Open Access   (Followers: 1, SJR: 0.119, CiteScore: 0)
Indian J. of Sexually Transmitted Diseases and AIDS     Open Access   (Followers: 2, SJR: 0.34, CiteScore: 0)
Indian J. of Social Psychiatry     Open Access   (Followers: 1)
Indian J. of Transplantation     Open Access  
Indian J. of Urology     Open Access   (Followers: 4, SJR: 0.434, CiteScore: 1)
Indian J. of Vascular and Endovascular Surgery     Open Access   (Followers: 2)
Indian Spine J.     Open Access  
Industrial Psychiatry J.     Open Access   (Followers: 2)
Intervention     Open Access   (Followers: 2)
Intl. Archives of Health Sciences     Open Access  
Intl. J. of Abdominal Wall and Hernia Surgery     Open Access   (Followers: 1)
Intl. J. of Academic Medicine     Open Access  
Intl. J. of Advanced Medical and Health Research     Open Access  
Intl. J. of Applied and Basic Medical Research     Open Access  
Intl. J. of Clinical and Experimental Physiology     Open Access   (Followers: 1)
Intl. J. of Clinicopathological Correlation     Open Access   (Followers: 1)
Intl. J. of Community Dentistry     Open Access  
Intl. J. of Critical Illness and Injury Science     Open Access   (Followers: 1, SJR: 0.192, CiteScore: 0)
Intl. J. of Educational and Psychological Researches     Open Access   (Followers: 4)
Intl. J. of Environmental Health Engineering     Open Access   (Followers: 1)
Intl. J. of Forensic Odontology     Open Access   (Followers: 1)
Intl. J. of Green Pharmacy     Open Access   (Followers: 8, SJR: 0.142, CiteScore: 0)
Intl. J. of Growth Factors and Stem Cells in Dentistry     Open Access  
Intl. J. of Health & Allied Sciences     Open Access   (Followers: 3)
Intl. J. of Health System and Disaster Management     Open Access   (Followers: 3)
Intl. J. of Heart Rhythm     Open Access  
Intl. J. of Medicine and Public Health     Open Access   (Followers: 6)
Intl. J. of Mycobacteriology     Open Access   (SJR: 0.535, CiteScore: 1)
Intl. J. of Noncommunicable Diseases     Open Access  
Intl. J. of Nutrition, Pharmacology, Neurological Diseases     Open Access   (Followers: 4, SJR: 0.17, CiteScore: 0)
Intl. J. of Oral Health Sciences     Open Access   (Followers: 3)
Intl. J. of Orofacial Biology     Open Access   (Followers: 1)
Intl. J. of Orofacial Research     Open Access   (Followers: 2)
Intl. J. of Orthodontic Rehabilitation     Open Access   (Followers: 1)
Intl. J. of Pedodontic Rehabilitation     Open Access  
Intl. J. of Pharmaceutical Investigation     Open Access   (Followers: 2)
Intl. J. of Preventive Medicine     Open Access   (Followers: 1, SJR: 0.623, CiteScore: 1)
Intl. J. of Shoulder Surgery     Open Access   (Followers: 5, SJR: 0.653, CiteScore: 1)
Intl. J. of the Cardiovascular Academy     Open Access   (SJR: 0.105, CiteScore: 0)
Intl. J. of Trichology     Open Access   (SJR: 0.4, CiteScore: 1)
Intl. J. of Yoga     Open Access   (Followers: 15)
Intl. J. of Yoga : Philosophy, Psychology and Parapsychology     Open Access   (Followers: 6)
Iranian J. of Nursing and Midwifery Research     Open Access   (Followers: 3)
Iraqi J. of Hematology     Open Access  
J. of Academy of Medical Sciences     Open Access  

        1 2 3 | Last   [Sort by number of followers]   [Restore default list]

Similar Journals
Journal Cover
Indian Journal of Drugs in Dermatology
Journal Prestige (SJR): 0.791
Citation Impact (citeScore): 1
Number of Followers: 1  

  This is an Open Access Journal Open Access journal
ISSN (Print) 2455-3972
Published by Medknow Publishers Homepage  [426 journals]
  • Review of oral anticholinergics in the treatment of palmoplantar
           hyperhidrosis

    • Authors: Swetalina Pradhan, Bhushan Madke, Chandra Sekhar Sirka
      Pages: 75 - 82
      Abstract: Swetalina Pradhan, Bhushan Madke, Chandra Sekhar Sirka
      Indian Journal of Drugs in Dermatology 2019 5(2):75-82
      Hyperhidrosis (HH) is the excessive production of sweating, which can be primary and focal or secondary. The most commonly affected sites are the armpits, palms, soles, and face. It causes much discomfort and affects self-esteem and quality of life. Many treatment options have been proposed, both medical and surgical. Several recent studies have documented the effectiveness of oral anticholinergics in both focal and generalized HH regardless of age, gender, and weight. This article is an attempt to update the current status of oral anticholinergics in the treatment of palmoplantar HH.
      Citation: Indian Journal of Drugs in Dermatology 2019 5(2):75-82
      PubDate: Mon,16 Dec 2019
      DOI: 10.4103/ijdd.ijdd_40_18
      Issue No: Vol. 5, No. 2 (2019)
       
  • Real-world experience on the effectiveness and tolerability of apremilast
           in patients with plaque psoriasis in India

    • Authors: Shrichand Parasramani, Jayakar Thomas, Leelavathy Budamakuntla, Dhiraj Dhoot, Hanmant Barkate
      Pages: 83 - 88
      Abstract: Shrichand Parasramani, Jayakar Thomas, Leelavathy Budamakuntla, Dhiraj Dhoot, Hanmant Barkate
      Indian Journal of Drugs in Dermatology 2019 5(2):83-88
      Introduction: Apremilast, a phosphodiesterase-4 inhibitor, has been recently approved for the management of plaque psoriasis in India in 2017. However, no real-world experience pertaining to apremilast has been documented. Materials and Methods: A retrospective review of medical records was conducted of all patients across India who were prescribed apremilast for an entire 16 weeks. The primary endpoint was the percentage of patients achieving the Psoriasis Area and Severity Index (PASI) 75 at 16 weeks. The secondary endpoints were as follows: (i) change in mean PASI; (ii) change in mean body surface area (BSA); (iii) percentage of patients who achieved PASI 50, 90, and 100; and (iv) adverse events (AEs) reported. Results: We analyzed the records of 105 patients. Mean age was 41 years and mean disease duration was 6.75 years. All the patients had previously received some forms of systemic treatment. Forty-three patients (41%) achieved ≥ PASI 75 of which four patients (3.8%) and five patients (4.76%) achieved PASI 100 and PASI 90, respectively at week 16. Moreover, 28 patients (26.7%) demonstrated PASI 50 response. Baseline mean PASI score of 14.78 reduced to 4.5 (−69.55%), whereas mean BSA score of 24.4 reduced to 8.24 (−66.3%). Nine patients discontinued apremilast due to adverse effects. Thirty-five patients (33.3%) had one or more AEs, diarrhea being the most common (30.5%) followed by nausea (20.3%). Most AEs were mild to moderate in severity. Conclusion: These results, from a real-world setting in India, confirm the effectiveness and tolerability of apremilast as seen in clinical trials.
      Citation: Indian Journal of Drugs in Dermatology 2019 5(2):83-88
      PubDate: Mon,16 Dec 2019
      DOI: 10.4103/ijdd.ijdd_16_19
      Issue No: Vol. 5, No. 2 (2019)
       
  • Assessment of cutaneous adverse drug reactions in a tertiary care hospital

    • Authors: Juny Sebastian, Madhan Ramesh, Chanchal Anandhy Mahin, Linda Jose, Vijayalaxmi Nagappa Sirasgi, Adhirai Raveendran
      Pages: 89 - 93
      Abstract: Juny Sebastian, Madhan Ramesh, Chanchal Anandhy Mahin, Linda Jose, Vijayalaxmi Nagappa Sirasgi, Adhirai Raveendran
      Indian Journal of Drugs in Dermatology 2019 5(2):89-93
      Introduction: Cutaneous adverse drug reactions (CADRs) are one of the significant clinical problems not only in dermatology practice but also in any areas where drug is involved. Aim: The aim of this study was to determine the incidence, pattern, predictors, and direct cost associated with the management of CADRs. Methodology: It was a prospective, observational study which involved both spontaneous reporting and intensive monitoring. Study patients were followed throughout their hospital stay. Where a CADR was detected, all the required data were collected and analyzed. Bivariate regression analysis was used to determine the predictors of CADRs. Results: The incidence of CADRs was 25.01%. Drug classes most commonly implicated in CADRs were antibiotics (29.055%), nonsteroidal anti-inflammatory drugs (17.31%), antineoplastic drugs (11.17%), and antitubercular drugs (10.05%). Majority (66.48%) of the reactions were “probable” in their causality category. Serious CADRs accounted for 1.67%. There was a significant association between the occurrence of CADRs and the use of ≥2 medications, adult patients, and male gender. The total and average costs incurred in the management of CADRs were INR 61,116/- and 734/-, respectively. Conclusion: Among the study population, adults, male gender, and patients receiving ≥2 medications and patients who presented with ≥2 comorbidities were identified as the predictors for the development of CADRs. Hence, it is important to monitor closely the patients with the identified risk factors for the CADRs to minimize the complications associated with the CADRs.
      Citation: Indian Journal of Drugs in Dermatology 2019 5(2):89-93
      PubDate: Mon,16 Dec 2019
      DOI: 10.4103/ijdd.ijdd_6_18
      Issue No: Vol. 5, No. 2 (2019)
       
  • Assessment of knowledge and attitude towards sun exposure and
           photoprotection measures among Indian patients attending dermatology
           clinic

    • Authors: Vivek Kumar Dey
      Pages: 94 - 99
      Abstract: Vivek Kumar Dey
      Indian Journal of Drugs in Dermatology 2019 5(2):94-99
      Background: Many skin diseases are known to be either initiated or aggravated by excessive ultraviolet (UV) exposure. High cumulative levels of UV radiation may lead to tanning, burning, photoaging, photoallergic and phototoxic reactions, immunosuppression, and even skin cancers. Many international studies have found that the level of knowledge, attitudes, and practices of the general public toward sun exposure and sun protection measures is good in the Western countries, especially in countries with high incidence of skin cancers compared to Asian countries and Middle East. In India, the incidence of skin cancer is not very high, but UV exposure has definitely increased in the past few decades. Little is known about the knowledge and attitude of Indians toward sun exposure and sun protection due to the paucity of research in this arena. Aims and Objectives: This study was aimed at exploring the knowledge and attitudes of Indians toward sun exposure and sun protection measures. Materials and Methods: A cross-sectional survey was conducted using a predesigned questionnaire related to the knowledge, behavior, and attitudes toward sun exposure and sun protection of the participants visiting a dermatology outpatient clinic for various dermatological problems. Results: total of 324 patients were studied. Participants were divided into five age groups of equal number of male and female participants. Mean age was 37.7 ± 13.15. Overall awareness and knowledge was poor and only 14% were using regular sunscreen. Females had better knowledge and attitude toward sun exposure and protection. The most commonly used sun protection measure was avoiding sun during peak hours of the day. Conclusion: The level of knowledge regarding sun exposure hazards was very low among the study population, and sun prevention behaviors were also very poor. Regular use of sunscreen was practiced only by a small fraction of our population. Knowledge of sun exposure and photoprotection was better in urban, young participants, female gender, and also positively associated with higher education and socioeconomic status. Participants from urban background, females, and middle-aged participants had better attitude toward photoprotection.
      Citation: Indian Journal of Drugs in Dermatology 2019 5(2):94-99
      PubDate: Mon,16 Dec 2019
      DOI: 10.4103/ijdd.ijdd_19_19
      Issue No: Vol. 5, No. 2 (2019)
       
  • Comparison of effectiveness of oral tranexamic acid with that of the
           topical modified Kligman's formula in the treatment of melasma

    • Authors: Aditi Bansal, Vidyadhar R Sardesai
      Pages: 100 - 103
      Abstract: Aditi Bansal, Vidyadhar R Sardesai
      Indian Journal of Drugs in Dermatology 2019 5(2):100-103
      Context: Melasma is an acquired disorder of hyperpigmentation presenting over the face. Modified Kligman's formula is used most commonly as treatment modality. Considering the various side effects of individual components of topical modified Kligman's formula, the use of oral tranexamic acid might be a better and safer alternative for the treatment of melasma. Aims: This study aims to compare the efficacy of oral tranexamic acid with that of topical modified Kligman's formula in the treatment of melasma. To assess the degree of improvement in pigmentation objectively using Melasma Area and Severity Index at baseline and after 4 weeks of treatment with oral tranexamic acid and topical modified Kligman's formula and to compare the side effects, if any, associated with both the modalities. Settings and Design: This was randomized, comparative, prospective, open-labeled study. Methods: This study was done in a tertiary care hospital from September 2018 to June 2019. Overall, 40 patients with clinical diagnosis of melasma were included in the study. Statistical Analysis Used: Paired t-test and unpaired t-test. Results: Improvement was noted in patients belonging to both the groups. After applying paired t-test, it was found that results were statistically significant in both the treatment groups. When both the groups were compared statistically using unpaired t-test, both the groups showed statistically equivalent results. Conclusions: Both oral tranexamic acid and modified Kligman's formula were equally effective in the treatment of melasma. Oral tranexamic acid is a better and safer alternative than the modified Kligman's formula to initiate the treatment in melasma.
      Citation: Indian Journal of Drugs in Dermatology 2019 5(2):100-103
      PubDate: Mon,16 Dec 2019
      DOI: 10.4103/ijdd.ijdd_52_19
      Issue No: Vol. 5, No. 2 (2019)
       
  • Inverse psoriasis with pityriasis amiantacea treated successfully with
           dapsone

    • Authors: Snehal Balavant Lunge, Manjunathswamy Basavapurad Swamy, Ashiwini Shivashankar Tatawati
      Pages: 104 - 106
      Abstract: Snehal Balavant Lunge, Manjunathswamy Basavapurad Swamy, Ashiwini Shivashankar Tatawati
      Indian Journal of Drugs in Dermatology 2019 5(2):104-106
      Inverse psoriasis, also known as intertriginous psoriasis, presents itself as erythematous plaques with poor or nondesquamation in skin flexion folds. Inverse psoriasis is a rare form of psoriasis associated with pityriasis amiantacea. This condition affects the intertriginous areas, making it difficult to diagnose and treat. Here, we report a case with lesions in the intertriginous area with pityriasis amiantacea in a patient of achondroplasia, who showed improvement with dapsone.
      Citation: Indian Journal of Drugs in Dermatology 2019 5(2):104-106
      PubDate: Mon,16 Dec 2019
      DOI: 10.4103/ijdd.ijdd_26_19
      Issue No: Vol. 5, No. 2 (2019)
       
  • D-penicillamine-induced elastosis perforans serpiginosa in a case of
           Wilson's disease

    • Authors: Shefali Saini, Vidya D Kharkar, Aabha Nagral
      Pages: 107 - 109
      Abstract: Shefali Saini, Vidya D Kharkar, Aabha Nagral
      Indian Journal of Drugs in Dermatology 2019 5(2):107-109
      The use of D-penicillamine has been well established in various disorders, mainly Wilson's disease, cystinuria, and rheumatoid arthritis. Elastosis perforans serpiginosa (EPS) is a rare perforating dermatosis, occurring as an uncommon sequel of long-term high-dose D-penicillamine therapy. We present a rare case of EPS in a known case of Wilson's Disease on D-penicillamine therapy. Biopsy revealed characteristic “lumpy-bumpy” elastic fibers, a finding specific to penicillamine-induced EPS.
      Citation: Indian Journal of Drugs in Dermatology 2019 5(2):107-109
      PubDate: Mon,16 Dec 2019
      DOI: 10.4103/ijdd.ijdd_53_19
      Issue No: Vol. 5, No. 2 (2019)
       
  • Good response to metronidazole in a case of erosive genital lichen planus

    • Authors: Vidya Kharkar, Anuja Sunkwad
      Pages: 110 - 112
      Abstract: Vidya Kharkar, Anuja Sunkwad
      Indian Journal of Drugs in Dermatology 2019 5(2):110-112

      Citation: Indian Journal of Drugs in Dermatology 2019 5(2):110-112
      PubDate: Mon,16 Dec 2019
      DOI: 10.4103/ijdd.ijdd_46_19
      Issue No: Vol. 5, No. 2 (2019)
       
  • Severe cutaneous adverse reaction after oral rechallenge test in a patient
           with fixed drug eruption due to doxycycline

    • Authors: Satyendra Kumar Singh, Ayushi Bohara
      Pages: 112 - 113
      Abstract: Satyendra Kumar Singh, Ayushi Bohara
      Indian Journal of Drugs in Dermatology 2019 5(2):112-113

      Citation: Indian Journal of Drugs in Dermatology 2019 5(2):112-113
      PubDate: Mon,16 Dec 2019
      DOI: 10.4103/ijdd.ijdd_20_19
      Issue No: Vol. 5, No. 2 (2019)
       
  • Solitary keratoacanthoma resolved after a single intralesional
           5-fluorouracil therapy

    • Authors: Amita Mhatre, Hari Shivaram Pathave
      Pages: 113 - 115
      Abstract: Amita Mhatre, Hari Shivaram Pathave
      Indian Journal of Drugs in Dermatology 2019 5(2):113-115

      Citation: Indian Journal of Drugs in Dermatology 2019 5(2):113-115
      PubDate: Mon,16 Dec 2019
      DOI: 10.4103/ijdd.ijdd_32_19
      Issue No: Vol. 5, No. 2 (2019)
       
  • A curious case of development of verruca vulgaris over the site of
           autoimplantation: Subsequently treated with measles, mumps and rubella
           vaccine

    • Authors: Alpana Mohta, Umesh Gautam, Ramesh Kumar Kushwaha, Suresh Kumar Jain
      Pages: 115 - 117
      Abstract: Alpana Mohta, Umesh Gautam, Ramesh Kumar Kushwaha, Suresh Kumar Jain
      Indian Journal of Drugs in Dermatology 2019 5(2):115-117

      Citation: Indian Journal of Drugs in Dermatology 2019 5(2):115-117
      PubDate: Mon,16 Dec 2019
      DOI: 10.4103/ijdd.ijdd_47_19
      Issue No: Vol. 5, No. 2 (2019)
       
  • Secukinumab in psoriasis

    • Authors: Col Manas Chatterjee, Sushil Pande
      Pages: 118 - 120
      Abstract: Col Manas Chatterjee, Sushil Pande
      Indian Journal of Drugs in Dermatology 2019 5(2):118-120

      Citation: Indian Journal of Drugs in Dermatology 2019 5(2):118-120
      PubDate: Mon,16 Dec 2019
      DOI: 10.4103/ijdd.ijdd_62_19
      Issue No: Vol. 5, No. 2 (2019)
       
  • News from regulatory corner: Safety communication and recent drug
           approvals

    • Authors: Manasi Shirolikar
      Pages: 121 - 122
      Abstract: Manasi Shirolikar
      Indian Journal of Drugs in Dermatology 2019 5(2):121-122

      Citation: Indian Journal of Drugs in Dermatology 2019 5(2):121-122
      PubDate: Mon,16 Dec 2019
      DOI: 10.4103/ijdd.ijdd_65_19
      Issue No: Vol. 5, No. 2 (2019)
       
 
JournalTOCs
School of Mathematical and Computer Sciences
Heriot-Watt University
Edinburgh, EH14 4AS, UK
Email: journaltocs@hw.ac.uk
Tel: +00 44 (0)131 4513762
 


Your IP address: 3.235.75.196
 
Home (Search)
API
About JournalTOCs
News (blog, publications)
JournalTOCs on Twitter   JournalTOCs on Facebook

JournalTOCs © 2009-